X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35) 35
humans (30) 30
melanoma (20) 20
middle aged (20) 20
female (18) 18
male (18) 18
oncology (18) 18
aged (17) 17
adult (16) 16
cancer (13) 13
melanoma - drug therapy (13) 13
aged, 80 and over (10) 10
dermatology (10) 10
ipilimumab (10) 10
metastatic melanoma (10) 10
skin neoplasms - drug therapy (10) 10
immunotherapy (9) 9
treatment outcome (9) 9
analysis (8) 8
metastasis (8) 8
animals (7) 7
nivolumab (7) 7
retrospective studies (7) 7
young adult (7) 7
antibodies, monoclonal - adverse effects (6) 6
antineoplastic agents - therapeutic use (6) 6
care and treatment (6) 6
chemistry (6) 6
materials science, multidisciplinary (6) 6
melanoma - mortality (6) 6
pembrolizumab (6) 6
programmed cell death 1 receptor - antagonists & inhibitors (6) 6
survival (6) 6
apoptosis (5) 5
chemotherapy (5) 5
clinical trials (5) 5
management (5) 5
melanoma - pathology (5) 5
metastases (5) 5
safety (5) 5
therapy (5) 5
adolescent (4) 4
antibodies (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
astrochemistry (4) 4
astronomy & astrophysics (4) 4
braf (4) 4
chemistry, physical (4) 4
cutaneous melanoma (4) 4
disease-free survival (4) 4
immune checkpoint (4) 4
immunology (4) 4
ism: molecules (4) 4
materials science (4) 4
medicine & public health (4) 4
metallurgy & metallurgical engineering (4) 4
prognosis (4) 4
quality of life (4) 4
research (4) 4
skin neoplasms - mortality (4) 4
skin neoplasms - pathology (4) 4
spectroscopy (4) 4
survival analysis (4) 4
toxicity (4) 4
alloys (3) 3
antibodies, monoclonal, humanized - adverse effects (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents, immunological - therapeutic use (3) 3
astrophysics - astrophysics of galaxies (3) 3
dacarbazine - adverse effects (3) 3
death (3) 3
dentistry (3) 3
disease (3) 3
drug therapy (3) 3
efficacy (3) 3
heart failure (3) 3
hematology, oncology and palliative medicine (3) 3
hydrogen (3) 3
immunohistochemistry (3) 3
malignant-melanoma (3) 3
melanoma - secondary (3) 3
methanol (3) 3
mutation (3) 3
neoplasm staging (3) 3
original (3) 3
patients (3) 3
samhällsvetenskap (3) 3
social sciences (3) 3
squamous-cell carcinoma (3) 3
studies (3) 3
survival rate (3) 3
tumors (3) 3
vemurafenib (3) 3
viral antibodies (3) 3
610 medicine & health (2) 2
abridged index medicus (2) 2
adjuvant therapy (2) 2
adsorption (2) 2
antibodies, monoclonal - administration & dosage (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Der Radiologe, ISSN 0033-832X, 2/2015, Volume 55, Issue 2, pp. 93 - 98
Die Inzidenz des Melanoms stieg in den letzten Jahrzehnten drastisch an. Da die Prognose maßgeblich von der Infiltrationstiefe abhängt, ist eine frühe Diagnose... 
Medicine & Public Health | Targeted therapy | Ipilimumab | MEK inhibitors | BRAF inhibitors | General Practice / Family Medicine | Immuntherapie | Immune therapy | Imaging / Radiology | Zielgerichtete Therapie | MEK-Inhibitoren | BRAF-Inhibitoren
Journal Article
Der Radiologe, ISSN 0033-832X, 02/2015, Volume 55, Issue 2, p. 93
Klinisches Problem Empfehlung fur die Praxis Clinical issue Practical recommendations 
Chemotherapy | PET imaging | Immunotherapy | Melanoma | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1845 - 1855
Journal Article
Annals of Oncology, ISSN 0923-7534, 2017, Volume 28, Issue 2, pp. 368 - 376
Journal Article
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 09/2017, Volume 31, Issue 9, pp. e389 - e391
Journal Article
Tumor Diagnostik und Therapie, ISSN 0722-219X, 10/2016, Volume 37, Issue 8, pp. 446 - 450
Journal Article
European Journal of Cancer, ISSN 0959-8049, 01/2019, Volume 106, pp. 220 - 224
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2014, Volume 25, Issue 3, pp. 700 - 706
Journal Article
European Journal of Cancer, ISSN 0959-8049, 02/2018, Volume 90, pp. 122 - 129
Immune checkpoint therapy has dramatically changed treatment options in patients with metastatic melanoma. However, a relevant part of patients still does not... 
NY-ESO-1 | Cancer/testis antigen | Immunotherapy | Ipilimumab | Melanoma | SURVIVAL | CTLA-4 BLOCKADE | ANTIBODY | CANCER | METASTATIC MELANOMA | T-CELL RESPONSES | ONCOLOGY | NIVOLUMAB | Clinical trials | Antigens | Immune response | Metastasis | Cell survival | Medical immunity | Medical services | Criteria | Disease control | Patients | Survival | Immunity | Metastases | Immune systems | Immune checkpoint | Biomarkers | Bioindicators | Tumors | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 03/2007, Volume 297, Issue 12, pp. 1332 - 1343
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 01/2018, Volume 32, Issue 1, pp. e31 - e32
Journal Article